Phacilitate 2019: Focus on Cord Blood Advocacy

​Join us for an inspiring morning focused on patient advocacy and education at the Phacilitate World Stem Cell Summit in Miami, January 25, 2019.


Could cord blood advocacy help your business?

Organized in co-operation with Save the Cord Foundation and chaired by Christina Celluzzi from AABB, this 90-minute session will cover the importance of advocacy and education in the cord blood community.  Featured speakers will include Charis Ober from Save the Cord Foundation,  Lizette Dunay from the CP Alliance Research Foundation and Amnon Pelz from Taburit. Each speaker will highlight why cord blood education and advocacy are pivotal for  business success and then go more in-depth during a dynamic panel discussing the power of partnerships. 
 
Presentations will cover: 

• Why patient advocacy is critical for the advancement of cord blood treatments;
• How advocacy sets your business apart;
• Why advocacy is beneficial to your brand and goodwill you can't buy.

Learn how various groups can work together within an industry to encourage growth and sustainability within the sector. Discover the missing piece of the puzzle:  Cord Blood Advocacy!
​

Learn more and register now for Phacilitate here.

---

Meet the speakers

​Christina M. Celluzzi, PhD, MS
Senior Manager, Cellular Therapies, AABB Center for Cellular Therapies

Dr. Celluzzi has a background in biomedical research which includes basic and applied research in cellular therapy (CT). She holds BS and MS degrees in Microbiology and earned her PhD in Medical Sciences at the University of Nijmegen in The Netherlands where she studied malarial immunity. Her entry into cellular therapies began with seminal research at the University of Pittsburgh investigating the role of dendritic cells (DC) in cytotoxic T-lymphocyte induction in melanoma. She continued in CT with the development of DC closed-culture systems and supporting assays for clinical application as research scientist and faculty member at the American Red Cross Holland Biomedical Laboratory and University of Maryland School of Medicine. She applies her more than 25 years of experience to her current position at AABB serving as a resource to its many CT professionals – helping to create and develop CT projects, including the Cellular Therapies Certificate Program.

---

Charis Ober
Founder and Executive Director of Save the Cord Foundation

Charis Ober is the Founder and Executive Director of Save The Cord Foundation, a US-based 501(c)3 non-profit charity.  She is a global advocate for umbilical cord blood education, awareness, research and legislation.  The Foundation is recognized worldwide for its innovative educational programs including Share the Science and World Cord Blood Day, to name a few. The Foundation is equally active at the state level working in collaboration with the Arizona Public Cord Blood Program.

​Mrs. Ober is a graduate of the University of Arizona and has more than 25 years of experience in pharmaceutical and biotech sales, marketing and product development.  Mrs. Ober lives in Tucson, Arizona with her husband, son and daughter.

---

​Lizette Dunay
Co-founder & Co-Executive Director, CURE CP 

Lizette is co-founder of Cure CP. She is a graduate of University of Florida where she got her B.A. in Economics and a minor in Spanish. For the past twelve years Lizette has worked in the medical and biologics field in a sales and business development capacity. For the past five years her career has focused on the area of regenerative medicine.

Lizette has always been very philanthropic and active in many different charities. Her belief in the science of regenerative medicine coupled with a desire to make life easier for her son and others with Cerebral Palsy is what drove her to start Cure CP. Lizette lives in Atlanta, GA with her husband and two children.

---

​Amnon Pelz
CEO of Taburit
​
Amnon Pelz is one of the developers and pioneers in the field of cord blood preservation in Israel, and is considered to be one of the most prominent experts in this field. As someone who connects scientific research, medical application, the insurance aspect and the business interface, Pelz is leading the cord blood preservation revolution to create a service accessible to the entire population and a shelf product available to everybody. Driven by his belief in the potential of stem cell therapy and his commitment to make new therapies based on Israeli scientific research available to the public, he is currently working to recruit investors from Israel and around the world and to connect them with Israeli medical centers.